The North America C-Reactive Protein Testing Market would witness market growth of 2.1% CAGR during the forecast period (2023-2030).
The liver produces the acute-phase protein called C-reactive protein (CRP), whose levels in the blood increase in response to inflammatory conditions. The level of CRP in the blood plasma is determined by the c-reactive protein (CRP) test. The body's response to an injury or disease is inflammation, which involves tissues being protected. Inflammation can be brought on by autoimmune conditions as well as chronic illnesses like diabetes, heart disease, cancer, endometriosis, and rheumatoid arthritis. The CRP protein can grow 1,000-fold in infected or inflamed tissues. The test is used to identify infections as well as other illnesses. The test measures the level of inflammation brought on by various causes, not the actual cause. It is a reliable early indicator of inflammation or injury.
Due to the increased prevalence of chronic diseases brought on by an aging population, more tests need to be performed. Furthermore, CRP testing in healthcare institutions is driven by sedentary lifestyles and weakened immune systems. Age-related increases in diagnostic testing usage are anticipated, and the demand will rise as the population increases. Comorbid conditions such as chronic diseases, osteoarthritis, and heart disease are more prevalent in older people. Therefore, the aforementioned reasons are expected to fuel market growth for CRP testing during the forecast period.
The leading cause of mortality in the United States for men, women, and members of most ethnic and racial communities is heart disease, according to the most recent statistics from the CDC, updated in May 2023. Cardiovascular disease claims a life in the United States every 33 seconds. In Canada, heart disease is the second largest cause of death. About 158,700 (6.1 per 1,000) Canadian people 20 years and older obtain an ischemic heart disease diagnosis yearly. Particularly, 63,200 (2.3 per 1,000) experienced their first heart attack. The market has development potential due to the rising rates of cancer and CVD in the region.
The US market dominated the North America C-reactive Protein Testing Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $875.1 million by 2030. The Canada market is anticipated to grow at a CAGR of 4.4% during (2023 - 2030). Additionally, The Mexico market would witness a CAGR of 3.5% during (2023 - 2030).
Based on Application, the market is segmented into Cardiovascular Disease, Inflammatory Bowel Disease, Rheumatoid Arthritis, Diabetes, and Others. Based on Assay Type, the market is segmented into Immunoturbidimetric Assays, Enzyme-linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), and Others. Based on End User, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide C-reactive Protein Testing Market is Projected to reach USD 3.5 Billion by 2030, at a CAGR of 2.8%
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Danaher Corporation, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Laboratory Corporation of America Holdings, Randox Laboratories Limited, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Horiba, Ltd., Merck KGaA, and Zoetis, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Cardiovascular Disease
- Inflammatory Bowel Disease
- Rheumatoid Arthritis
- Diabetes
- Others
By Assay Type
- Immunoturbidimetric Assays
- Enzyme-linked Immunosorbent Assay (ELISA)
- Chemiluminescence Immunoassay (CLIA)
- Others
By End User
- Hospitals & Clinics
- Diagnostic Laboratories
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Danaher Corporation
- F. Hoffmann-La Roche Ltd
- Abbott Laboratories
- Laboratory Corporation of America Holdings
- Randox Laboratories Limited
- Thermo Fisher Scientific Inc.
- Quest Diagnostics Incorporated
- Horiba, Ltd.
- Merck KGaA
- Zoetis, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America C-reactive Protein Testing Market, by Application
1.4.2 North America C-reactive Protein Testing Market, by Assay Type
1.4.3 North America C-reactive Protein Testing Market, by End User
1.4.4 North America C-reactive Protein Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Force Analysis
Chapter 4. North America C-reactive Protein Testing Market by Application
4.1 North America Cardiovascular Disease Market by Country
4.2 North America Inflammatory Bowel Disease Market by Country
4.3 North America Rheumatoid Arthritis Market by Country
4.4 North America Diabetes Market by Country
4.5 North America Others Market by Country
Chapter 5. North America C-reactive Protein Testing Market by Assay Type
5.1 North America Immunoturbidimetric Assays Market by Country
5.2 North America Enzyme-linked Immunosorbent Assay (ELISA) Market by Country
5.3 North America Chemiluminescence Immunoassay (CLIA) Market by Country
5.4 North America Others Market by Country
Chapter 6. North America C-reactive Protein Testing Market by End User
6.1 North America Hospitals & Clinics Market by Country
6.2 North America Diagnostic Laboratories Market by Country
6.3 North America Others Market by Country
Chapter 7. North America C-reactive Protein Testing Market by Country
7.1 US C-reactive Protein Testing Market
7.1.1 US C-reactive Protein Testing Market by Application
7.1.2 US C-reactive Protein Testing Market by Assay Type
7.1.3 US C-reactive Protein Testing Market by End User
7.2 Canada C-reactive Protein Testing Market
7.2.1 Canada C-reactive Protein Testing Market by Application
7.2.2 Canada C-reactive Protein Testing Market by Assay Type
7.2.3 Canada C-reactive Protein Testing Market by End User
7.3 Mexico C-reactive Protein Testing Market
7.3.1 Mexico C-reactive Protein Testing Market by Application
7.3.2 Mexico C-reactive Protein Testing Market by Assay Type
7.3.3 Mexico C-reactive Protein Testing Market by End User
7.4 Rest of North America C-reactive Protein Testing Market
7.4.1 Rest of North America C-reactive Protein Testing Market by Application
7.4.2 Rest of North America C-reactive Protein Testing Market by Assay Type
7.4.3 Rest of North America C-reactive Protein Testing Market by End User
Chapter 8. Company Profiles
8.1 Danaher Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 F. Hoffmann-La Roche Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 SWOT Analysis
8.3 Abbott Laboratories
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 SWOT Analysis
8.4 Thermo Fisher Scientific, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 SWOT Analysis
8.5 Horiba Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional & Segmental Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 Randox Laboratories Limited
8.6.1 Company Overview
8.6.2 SWOT Analysis
8.7 Zoetis, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Quest Diagnostics Incorporated
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental Analysis
8.8.4 SWOT Analysis
8.9 Laboratory Corporation of America Holdings
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental Analysis
8.9.4 SWOT Analysis
8.10. Merck KGaA
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expense
8.10.5 SWOT Analysis
TABLE 1 North America C-reactive Protein Testing Market, 2019 - 2022, USD Million
TABLE 2 North America C-reactive Protein Testing Market, 2023 - 2030, USD Million
TABLE 3 North America C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
TABLE 4 North America C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
TABLE 5 North America Cardiovascular Disease Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Cardiovascular Disease Market by Country, 2023 - 2030, USD Million
TABLE 7 North America Inflammatory Bowel Disease Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Inflammatory Bowel Disease Market by Country, 2023 - 2030, USD Million
TABLE 9 North America Rheumatoid Arthritis Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Rheumatoid Arthritis Market by Country, 2023 - 2030, USD Million
TABLE 11 North America Diabetes Market by Country, 2019 - 2022, USD Million
TABLE 12 North America Diabetes Market by Country, 2023 - 2030, USD Million
TABLE 13 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 14 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 15 North America C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
TABLE 16 North America C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
TABLE 17 North America Immunoturbidimetric Assays Market by Country, 2019 - 2022, USD Million
TABLE 18 North America Immunoturbidimetric Assays Market by Country, 2023 - 2030, USD Million
TABLE 19 North America Enzyme-linked Immunosorbent Assay (ELISA) Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Enzyme-linked Immunosorbent Assay (ELISA) Market by Country, 2023 - 2030, USD Million
TABLE 21 North America Chemiluminescence Immunoassay (CLIA) Market by Country, 2019 - 2022, USD Million
TABLE 22 North America Chemiluminescence Immunoassay (CLIA) Market by Country, 2023 - 2030, USD Million
TABLE 23 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 25 North America C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
TABLE 26 North America C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
TABLE 27 North America Hospitals & Clinics Market by Country, 2019 - 2022, USD Million
TABLE 28 North America Hospitals & Clinics Market by Country, 2023 - 2030, USD Million
TABLE 29 North America Diagnostic Laboratories Market by Country, 2019 - 2022, USD Million
TABLE 30 North America Diagnostic Laboratories Market by Country, 2023 - 2030, USD Million
TABLE 31 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 32 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 33 North America C-reactive Protein Testing Market by Country, 2019 - 2022, USD Million
TABLE 34 North America C-reactive Protein Testing Market by Country, 2023 - 2030, USD Million
TABLE 35 US C-reactive Protein Testing Market, 2019 - 2022, USD Million
TABLE 36 US C-reactive Protein Testing Market, 2023 - 2030, USD Million
TABLE 37 US C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
TABLE 38 US C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
TABLE 39 US C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
TABLE 40 US C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
TABLE 41 US C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
TABLE 42 US C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
TABLE 43 Canada C-reactive Protein Testing Market, 2019 - 2022, USD Million
TABLE 44 Canada C-reactive Protein Testing Market, 2023 - 2030, USD Million
TABLE 45 Canada C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
TABLE 46 Canada C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
TABLE 47 Canada C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
TABLE 48 Canada C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
TABLE 49 Canada C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
TABLE 50 Canada C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
TABLE 51 Mexico C-reactive Protein Testing Market, 2019 - 2022, USD Million
TABLE 52 Mexico C-reactive Protein Testing Market, 2023 - 2030, USD Million
TABLE 53 Mexico C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
TABLE 54 Mexico C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
TABLE 55 Mexico C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
TABLE 56 Mexico C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
TABLE 57 Mexico C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
TABLE 58 Mexico C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
TABLE 59 Rest of North America C-reactive Protein Testing Market, 2019 - 2022, USD Million
TABLE 60 Rest of North America C-reactive Protein Testing Market, 2023 - 2030, USD Million
TABLE 61 Rest of North America C-reactive Protein Testing Market by Application, 2019 - 2022, USD Million
TABLE 62 Rest of North America C-reactive Protein Testing Market by Application, 2023 - 2030, USD Million
TABLE 63 Rest of North America C-reactive Protein Testing Market by Assay Type, 2019 - 2022, USD Million
TABLE 64 Rest of North America C-reactive Protein Testing Market by Assay Type, 2023 - 2030, USD Million
TABLE 65 Rest of North America C-reactive Protein Testing Market by End User, 2019 - 2022, USD Million
TABLE 66 Rest of North America C-reactive Protein Testing Market by End User, 2023 - 2030, USD Million
TABLE 67 Key Information – Danaher Corporation
TABLE 68 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 69 Key Information – Abbott Laboratories
TABLE 70 Key Information – Thermo Fisher Scientific, Inc.
TABLE 71 Key Information – Horiba Ltd.
TABLE 72 Key Information – randox laboratories limited
TABLE 73 Key Information – Zoetis, Inc.
TABLE 74 Key information – Quest Diagnostics Incorporated
TABLE 75 Key Information – Laboratory Corporation of America holdings
TABLE 76 key Information – Merck KGaA
List of Figures
FIG 1 Methodology for the research
FIG 2 North America C-reactive Protein Testing Market, 2019 - 2030, USD Million
FIG 3 Key Impacting Factors C-reactive protein testing market
FIG 4 Porter’s Five Force Analysis: C-Reactive Protein Testing Market
FIG 5 North America C-reactive Protein Testing Market share by Application, 2022
FIG 6 North America C-reactive Protein Testing Market share by Application, 2030
FIG 7 North America C-reactive Protein Testing Market by Application, 2019 - 2030, USD Million
FIG 8 North America C-reactive Protein Testing Market share by Assay Type, 2022
FIG 9 North America C-reactive Protein Testing Market share by Assay Type, 2030
FIG 10 North America C-reactive Protein Testing Market by Assay Type, 2019 - 2030, USD Million
FIG 11 North America C-reactive Protein Testing Market share by End User, 2022
FIG 12 North America C-reactive Protein Testing Market share by End User, 2030
FIG 13 North America C-reactive Protein Testing Market by End User, 2019 - 2030, USD Million
FIG 14 North America C-reactive Protein Testing Market share by Country, 2022
FIG 15 North America C-reactive Protein Testing Market share by Country, 2030
FIG 16 North America C-reactive Protein Testing Market by Country, 2019 - 2030, USD Million
FIG 17 SWOT Analysis: Danaher Corporation
FIG 18 Swot Analysis: F. Hoffmann-La Roche Ltd.
FIG 19 SWOT Analysis: Abbott Laboratories
FIG 20 Swot Analysis: Thermo Fisher Scientific, Inc.
FIG 21 Swot Analysis: Horiba Ltd.
FIG 22 SWOT Analysis: Randox Laboratories Limited
FIG 23 SWOT Analysis: Zoetis, Inc.
FIG 24 SWOT Analysis: Quest Diagnostics Incorporated
FIG 25 SWOT Analysis: Laboratory Corporation of America Holdings
FIG 26 Swot Analysis: Merck KGaA